Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director | August 14, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 381,989 |
Reported balance
After 2026-08-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-14 · Sale · Disposed 5,973 · Balance 381,989 |
| Common StockSEC Table I · non-derivative | Direct | 47,156 |
Reported balance
Holding disclosure · report date 2026-08-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 47,156 F1: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount reported includes shares subject to unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2021 Filed Jul 23, 2021 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 100,000 | $5.92 | $592,460.00 |
DisclosureSEC source: 0001654954-21-008166 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 847,055 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $7.453, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:35 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007936 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 947,055 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 22:12 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon stock | 8,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-004497 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 941,082 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 7,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000676 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 932,669 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 01:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-20-011335 · section16.xml · derivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2027-10-20 F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 01:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 13,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011335 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 924,891 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 00:25 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007784 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 911,831 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 01:34 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,956 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-004301 · section16.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,956 Underlying: Common Stock · 17,956 shares Expires 2027-04-21 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · derivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 30,000 | $2.27 | $68,100.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 30,000 | $1.28 | $38,400.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY2019 of 1,960 shares on 11/22/2019. The closing price was $2.02 per share. Read SEC document |
| October 22, 2019 Filed Oct 23, 2019 23:09 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011956 · section16.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000015 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 27, 2019 00:00 UTC Amendment | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherNon-Qualified Stock Option(right to buy) · Derivative | 0 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000018 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed F1 · kind: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. F1 · derivative.exercise_date: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. F1 · derivative.expiration_date: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 01:35 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001040470-18-000047 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2025-08-17 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 27, 2017 Filed Jul 27, 2017 21:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,500 | $4.14 | $6,210.00 |
DisclosureSEC source: 0001040470-17-000053 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 899,214 Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 23:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $4.14 | $41,400.00 |
DisclosureSEC source: 0001040470-17-000050 · primary_doc.xml · nonDerivative · entry 5 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 900,714 Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 23:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $4.09 | $40,910.00 |
DisclosureSEC source: 0001040470-17-000050 · primary_doc.xml · nonDerivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 910,714 Read SEC document |
| July 25, 2017 Filed Jul 25, 2017 23:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,056 | $4.05 | $40,726.80 |
DisclosureSEC source: 0001040470-17-000050 · primary_doc.xml · nonDerivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 920,714 Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 23:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 9,944 | $4.05 | $40,273.20 |
DisclosureSEC source: 0001040470-17-000050 · primary_doc.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 930,770 Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 23:23 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $4.04 | $40,390.00 |
DisclosureSEC source: 0001040470-17-000050 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 940,714 Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:59 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001040470-17-000045 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2024-07-11 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001040470-17-000039 · primary_doc.xml · derivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2017-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 40,000 | $1.40 | $55,924.00 |
DisclosureSEC source: 0001040470-17-000039 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 950,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 21:32 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 844 | $3.54 | $2,987.76 |
DisclosureSEC source: 0001040470-16-000148 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 910,714 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,156 | $3.54 | $14,712.24 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 6 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 911,558 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $3.49 | $17,450.00 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 5 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 915,714 Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $3.45 | $17,250.00 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 920,714 Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,000 | $3.24 | $3,240.00 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 925,714 Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,467 | $3.16 | $14,115.72 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 926,714 Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 21:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $3.14 | $23,550.00 |
DisclosureSEC source: 0001040470-16-000146 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 931,181 Read SEC document |
| October 25, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $3.16 | $23,700.00 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 6 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 938,681 Read SEC document |
| October 25, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $3.14 | $23,550.00 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 5 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 946,181 Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,493 | $3.12 | $14,018.16 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 953,681 Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $3.09 | $15,450.00 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 958,174 Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $3.03 | $15,150.00 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 963,174 Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 17:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,900 | $2.99 | $8,671.00 |
DisclosureSEC source: 0001040470-16-000144 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 968,174 Read SEC document |
| October 21, 2016 Filed Oct 21, 2016 22:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,300 | $2.99 | $3,887.00 |
DisclosureSEC source: 0001040470-16-000141 · primary_doc.xml · nonDerivative · entry 5 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 971,074 Read SEC document |
| October 21, 2016 Filed Oct 21, 2016 22:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 800 | $3.00 | $2,400.00 |
DisclosureSEC source: 0001040470-16-000141 · primary_doc.xml · nonDerivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 972,374 Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 22:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $3.03 | $15,150.00 |
DisclosureSEC source: 0001040470-16-000141 · primary_doc.xml · nonDerivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 973,174 Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 22:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $2.99 | $14,950.00 |
DisclosureSEC source: 0001040470-16-000141 · primary_doc.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 978,174 Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 22:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $2.96 | $14,800.00 |
DisclosureSEC source: 0001040470-16-000141 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 983,174 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,190 | $3.04 | $3,617.60 |
DisclosureSEC source: 0001040470-16-000129 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 988,174 Read SEC document |
| October 04, 2016 Filed Oct 5, 2016 21:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 500 | $3.20 | $1,600.00 |
DisclosureSEC source: 0001040470-16-000126 · primary_doc.xml · nonDerivative · entry 3 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 989,364 Read SEC document |
| October 04, 2016 Filed Oct 5, 2016 21:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 500 | $3.15 | $1,575.00 |
DisclosureSEC source: 0001040470-16-000126 · primary_doc.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 989,864 Read SEC document |
| October 04, 2016 Filed Oct 5, 2016 21:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 925 | $3.09 | $2,858.25 |
DisclosureSEC source: 0001040470-16-000126 · primary_doc.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 990,364 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.